The present report presents a rare case in which a patient with pituitary apoplexy (PA) without compression of the optic chiasm experienced diagnosable visual impairment in the ensuing months. Endocrinologically, the condition was a prolactinoma followed by bleeding into the pituitary gland. Due to the unexplained functional changes in the patient, an electrophysiological examination (pattern electroretinogram and pattern visual evoked potentials) was performed, which verified a bilateral non-inflammatory neurogenic lesion. This finding was confirmed by functional magnetic resonance imaging (fMRI) examination. Structural MRI did not reveal chiasm compression in the time sequence or alteration of the optic nerves (the diameter of the optic nerve at different distances from the eye and the diameter of the optic nerve sheath at different distances from the eye). Similarly, neither the retinal nerve fiber layer (RNFL) nor the vessel density was altered. The present report suggests that changes in visual fields may be due to ischemia in the area of the chiasm and optic nerves, similar to PA.

1st Clinic of Internal Medicine Department of Endocrinology University Hospital in Pilsen 301 00 Pilsen Czech Republic

Department of Ophthalmology University Hospital in Pilsen 301 00 Pilsen Czech Republic

Faculty of Biomedical Engineering Czech Technical University Prague 272 01 Kladno Czech Republic

Zobrazit více v PubMed

Otradovec J, Jindrová M. Pituitary apoplexy. Cesk Oftalmol. 1972;28:329–333. (In Czech) PubMed

Fernandez A, Karavitaki N, Wass JA. Prevalence of pituitary adenomas: A community-based, cross-sectional study in Banbury (Oxfordshire, UK) Clin Endocrinol. 2010;72:377–382. doi: 10.1111/j.1365-2265.2009.03667.x. PubMed DOI

Brougham M, Heusner AP, Adams RD. Acute degenerative changes in adenomas of the pituitary body with special reference to pituitary apoplexy. J Neurosurg. 1950;7:421–439. doi: 10.3171/jns.1950.7.5.0421. PubMed DOI

Dan NG, Feiner RI, Houang MT, Turner JJ. Pituitary apoplexy in association with lymphocytic hypophysitis. J Clin Neurosci. 2002;9:577–580. doi: 10.1054/jocn.2001.0975. PubMed DOI

Husain Q, Zouzias A, Kanumuri VV, Eloy JA, Liu JK. Idiopathic granulomatous hypophysitis presenting as pituitary apoplexy. J Clin Neurosc. 2014;21:510–512. doi: 10.1016/j.jocn.2013.05.002. PubMed DOI

Chhiber SS, Bhat AR, Khan SH, Wani MA, Ramzan AU, Kirmani AR, Malik NK, Wani AA, Rather T. Apoplexy in sellar metastasis: A case report and review of literature. Turk Neurosurg. 2011;21:230–234. doi: 10.5137/1019-5149.JTN.2716-09.1. PubMed DOI

Chaiban JT, Abdelmannan D, Cohen M, Selman WR, Arafah BM. Rathke cleft cyst apoplexy: A newly characterized distinct clinical entity. J Neurosurgery. 2011;114:318–324. doi: 10.3171/2010.5.JNS091905. PubMed DOI

Trifanescu R, Ansorge O, Wass JA, Grossman AB, Karavitaki N. Rathke's cleft cysts. Clin Endocrinol (Oxf) 2012;76:151–160. doi: 10.1111/j.1365-2265.2011.04235.x. PubMed DOI

Schar RT, Vajtai I, Sahli R, Seiler RW. Manifestation of a sellar hemangioblastoma due to pituitary apoplexy: A case report. J Med Case Rep. 2011;5(496) doi: 10.1186/1752-1947-5-496. PubMed DOI PMC

Möller-Goede DL, Brändle M, Landau K, Bernays RL, Schmid C. Pituitary apoplexy: Re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome. Eur J Endocrinol. 2011;164:37–43. doi: 10.1530/EJE-10-0651. PubMed DOI

Capatina C, Inder W, Karavitaki N, Wass JA. Management of endocrine disease: Pituitary tumour apoplexy. Eur J Endocrinol. 2015;172:R179–R190. doi: 10.1530/EJE-14-0794. PubMed DOI

Glezer A, Bronstein MD. Pituitary apoplexy: Pathophysiology, diagnosis and management. Arch Endocrinol Metab. 2015;59:259–264. doi: 10.1590/2359-3997000000047. PubMed DOI

Park M, Lee SK, Choi J, Kim SH, Kim SH, Shin NY, Kim J, Ahn SS. Differentiation between cystic pituitary adenomas and rathke cleft cysts: A diagnostic model using MRI. Am J Neuroradiol. 2015;36:1866–1873. doi: 10.3174/ajnr.A4387. PubMed DOI PMC

Lešták J, Tintěra J. Functional magnetic resonance imaging in selected eye diseases. Cesk Slov Oftalmol. 2015;71:127–133. (In Czech) PubMed

Otradovec J. Klinická Neurooftalmologie. GRADA Publishing, Prague, 2003. (In Czech).

Slamovits TL, Burde R. Neuro-ophthalmology. Textbook of Ophthalmology. Vol. 6. Mosby, 1994.

Kyncl M, Lestak J, Sverepa M, Ettler L, Rozsival P. The anterior visual pathway in normal-tension glaucoma. Papirex-Indian J Res. 2015;4:10–13.

Lešták J, Kyncl M, Fůs M, Marešová K. Optic chiasm width in normotensive and hypertensive glaucomas. Cesk Slov Oftalmol. 2020;76:126–128. doi: 10.31348/2020/21. PubMed DOI

Danesh-Meyer HV, Wong A, Papchenko T, Matheos K, Stylli S, Nichols A, Frampton C, Daniell M, Savino PJ, Kaye AH. Optical coherence tomography predicts visual outcome for pituitary tumours. J Clin Neurosci. 2015;22:1098–1104. doi: 10.1016/j.jocn.2015.02.001. PubMed DOI

Yoneoka Y, Hatase T, Watanabe N, Jinguji S, Okada M, Takagi M, Fujii Y. Early morphological recovery of the optic chiasm is associated with excellent visual outcome in patients with compressive chiasmal syndromecaused by pituitary tumours. Neurol Res. 2015;37:1–8. doi: 10.1179/1743132814Y.0000000407. PubMed DOI

Póczoš P, Kremláček J, Česák T, Macháčková M, Jirásková N. The use of optical coherence tomography in chiasmal compression. Cesk Slov Oftalmol. 2019;75:120–127. doi: 10.31348/2019/3/2. PubMed DOI

Lestak J, Kalvodova B, Karel I, Tintera J. Functional magnetic resonance imaging following epimacular and internal limiting membrane peeling-ipsilateral and contralateral findings. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020;164:273–276. doi: 10.5507/bp.2019.044. PubMed DOI

Chouinard PA, Striemer CL, Ryu WH, Sperandio I, Goodale MA, Nicolle DA, Rotenberg B, Duggal N. Retinotopic organization of the visual cortex before and after decompression of the optic chiasm in a patient with pituitary macroadenoma. J Neurosurg. 2012;117:218–224. doi: 10.3171/2012.4.JNS112158. PubMed DOI

Sarwar KN, Huda MS, Van de Velde V, Hopkins L, Luck S, Preston R, McGowan BM, Carroll PV, Powrie JK. The prevalence and natural history of pituitary haemorrhage in prolactinoma. J Clin Endocrinol Metab. 2013;986:2362–2367. doi: 10.1210/jc.2013-1249. PubMed DOI

Chuman H, Cornblath WT, Trobe JD, Gebarski SS. Delayed visual loss following pergolide treatment of a prolactinoma. J Neuroophthalmol. 2002;22:102–106. doi: 10.1097/00041327-200206000-00008. PubMed DOI

Raverot G, Jacob M, Jouanneau E, Delemer B, Vighetto A, Pugeat M, Borson-Chazot F. Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma. Clin Endocrinol (Oxf) 2009;70:588–592. doi: 10.1111/j.1365-2265.2008.03364.x. PubMed DOI